North America Travel Vaccines Market Analysis/Forecasts 2021-2022 & 2028: Surging Travel and Tourism & Never-ending Demand for Vaccines - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Application" report has been added to ResearchAndMarkets.com's offering.

The travel vaccines market in North America is expected to grow from US$ 1,276.32 million in 2021 to US$ 2,503.59 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

Travelling outside the country requires immunization as a safety and precautionary measure to avoid spreading infections. Various countries have policies to protect their citizens from travel-associated infections. The above estimates suggest that travel and tourism will increase in the coming years.

Furthermore, economic crises and demand for better job opportunities contributed to the increasing travel and tourism across the region. Thus, the increasing travel and tourism propel the demand for travel vaccines.

Furthermore, economic crises and demand for better job opportunities have contributed to the increasing travel and tourism worldwide. Thus, the increasing travel and tourism propel the demand for travel vaccines.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America travel vaccines market . The North America travel vaccines market is expected to grow at a good CAGR during the forecast period.

North America Travel Vaccines Market Segmentation

• The North America travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market.
• By application, the North America travel vaccines market is segmented into domestic and outbound travel. In 2021, the outbound travel segment held the largest share of the market.
• Based on country, the North America travel vaccines market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.

Key Market Dynamics

Market Drivers

• Surging Travel and Tourism
• Rising Incidences of Infectious Diseases

Market Restraints

• High Cost of Travel Vaccines

Market Opportunities

• Rising Awareness Regarding Vaccines

Future Trends

• Never-ending Demand for Vaccines

Company Profiles

• Abbott
• Dynavax Technologies
• Emergent BioSolutions Inc.
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Valneva SE.

For more information about this report visit https://www.researchandmarkets.com/r/7if20q